‘Game-changer’: drug exceeds expectations in Covid trial
The treatment not only helps the lungs’ ability to neutralise the virus, but could also tackle a mutated version
A “game-changing” treatment for Covid-19 could reduce the chance of serious illness by 80%, research suggests.
Trials using an inhaled protein, which is commonly used to treat multiple sclerosis, found that patients given it were more than twice as likely to recover during the treatment period, compared with those given a placebo.
Stays in hospital were cut by a third, according to the study of hospital patients in Southampton, England...